FCGR1A and acute myeloid leukemia: Beyond other factors, limited efficacy may be attributed to the expression of CD64 (FcγRI) on AML cells, which is the high-affinity FcγR receptor for IgG1 antibodies and has been shown to interfere with ADCC of IgG1 antibodies42,43.